Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prediction of Response to Targeted Treatment in Rheumatoid Arthritis.

Mayo Clinic proceedings - 1 Jul 2017

Wijbrandts C A, Tak P P

Abstract excerpt

Rheumatoid arthritis is an autoimmune syndrome presenting with chronic inflammation of the joints. Patients with the same diagnosis can present with different phenotypes. In some patients severe joint inflammation and early joint destruction are observed, whereas a milder phenotype can be seen in others. Conversely, patients with the same signs and symptoms may exhibit different immunological and molecular...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antirheumatic Agents
Share to Arthritis, Rheumatoid
Share to Disease Progression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Inflammation

Share to Phenotype

Share to Treatment Outcome

Source

Identifiers

PMID: 28688467
DOI: 10.1016/j.mayocp.2017.05.009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prediction of Response to Targeted Treatment in Rheumatoid Arthritis.PMID 28688467Read ↗

The evolution of biomarkers in rheumatoid arthritis: from clinical research to clinical care.Semantic proximity Read ↗

Predictive factors of response to biological disease modifying antirheumatic drugs: towards personalized medicine.Semantic proximity Read ↗

Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and PharmacogeneticsSemantic proximity Read ↗

Can rheumatoid arthritis responsiveness to methotrexate and biologics be predicted?Semantic proximity Read ↗

Optimising treatment in rheumatoid arthritis: a review of potential biological markers of response.Semantic proximity Read ↗

Rheumatoid Arthritis Pathogenesis, Prediction, and Prevention: An Emerging Paradigm Shift.Semantic proximity Read ↗

[Predictors of response to biologic therapies in rheumatoid arthritis].Semantic proximity Read ↗

Biomarkers for rheumatoid arthritis: From molecular processes to diagnostic applications-current concepts and future perspectivesSemantic proximity Read ↗

Precision medicine and management of rheumatoid arthritis.Semantic proximity Read ↗

PREDIRA (PRediction mEdical DevIce for Rheumatoid Arthritis): Scale-up of unique predictive online platform highly improving the quality of life of Rheumatoid Arthritis’ patient by personalized and efficient biotherapies prescriptionSemantic proximity Read ↗

Frontiers in Rheumatoid Arthritis: Emerging Research and Unmet Needs in Pharmacologic ManagementSemantic proximity Read ↗

Clinical Phenotypes, Serological Biomarkers, and Synovial Features Defining Seropositive and Seronegative Rheumatoid Arthritis: A Literature Review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.